MDA-MB-453 and BT-474 cells were grown in DMEM/F12 media (Gibco) supplemented with 10% fetal bovine serum (FBS) (Thermo Fisher), 2 mM L-glutamine (Thermo Fisher), amphotericin B 2.5 g/mL (Gibco), 100 U/mL penicillin/100 g/mL streptomycin (Thermo Fisher) and, only with the BT-474 cell lines, 10 g/ml insulin (Merck) were added
naturally balanced and preserved
In another study, researchers discovered that tirzepatide treatment, when combined with a decrease in circulating levels of branched-chain amino (BCAA) and keto (BCKA) acid metabolites linked to the development of systemic insulin resistance (IR) and T2DM improves insulin sensitivity in obese mice and humans with T2DM [82]
As with any therapy, however, there is some risk of side effects, although they are notably rare and mild in the case of semaglutide, and primarily affect the gastrointestinal tract